EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Pan-Immune-Inflammation Value as a Novel Predictor of Contrast-Associated Acute Kidney Injury in Patients Treated with Primary PCI for STEMI

Gökhan Çiçek, Sadık Kadri Açıkgöz, Eser Açıkgöz, Servet Altay

Journal of Clinical Medicine · 23.03.2026 · 15 (6) · 2456

DOI: 10.3390/jcm15062456 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 23.03.2026. Verfasst von Gökhan Çiçek und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Ankara Bilkent City Hospital, University of Health Sciences, 06800 Ankara, Türkiye. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Contrast-associated acute kidney injury (CA-AKI) remains an important cause of morbidity and mortality in patients undergoing procedures that require intravascular contrast administration. Therefore, the early identification of high-risk individuals is paramount, above all for ST-segment elevation myocardial infarction (STEMI) patients in need of urgent percutaneous coronary intervention (PCI).

Methods

This retrospective study evaluated the prognostic value of the Pan-Immune-Inflammation Value (PIV), a composite inflammatory index, in predicting CA-AKI among patients presenting with STEMI who received urgent PCI within a 12 h window from the onset of symptoms.

Results

This study recruited 2325 patient. CA-AKI was defined as a >25% or ≥0.5 mg/dL increase in serum creatinine within 48–72 h after the procedure. Patients were categorized into CA-AKI (+) and CA-AKI (−) groups. PIV levels were significantly higher in patients who developed CA-AKI (502.5 ± 324.5 vs. 264.7 ± 165.8; p < 0.001). ROC analysis identified a PIV cutoff value of >320, yielding an AUC of 0.753 (95% CI: 0.740–0.787; p < 0.001), with 67% sensitivity and 66.9% specificity. Multivariate logistic regression confirmed that PIV > 320 independently predicted CA-AKI (OR 2.118; 95% CI: 1.329–3.790; p < 0.001). In multivariable analysis, age, Killip class, contrast volume, and PIV > 320 were identified as independent predictors of CA-AKI.

Conclusions

Elevated admission PIV serves as an independent and practical biomarker for predicting CA-AKI in STEMI patients undergoing PCI.

Schlagwörter

Stichwörter der Autor:innen

ST-segment elevation myocardial infarction (STEMI)cardiovascular diseasecontrast-associated acute kidney injurypan-immune-inflammation valueprimary percutaneous coronary intervention

Autor:innen und Institutionen

  • Department of Cardiology, Ankara Bilkent City Hospital, University of Health Sciences, 06800 Ankara, Türkiye.
  • Department of Cardiology, Abdurrahman Yurtaslan Oncology Education and Research Hospital, 06800 Ankara, Türkiye.
  • Department of Cardiology, Faculty of Medicine, Trakya University, 22030 Edirne, Türkiye.

Zitieren

APA

Çiçek, G., Açıkgöz, S. K., Açıkgöz, E., & Altay, S. (2026). Pan-Immune-Inflammation Value as a Novel Predictor of Contrast-Associated Acute Kidney Injury in Patients Treated with Primary PCI for STEMI. Journal of Clinical Medicine, 15(6), 2456. https://doi.org/10.3390/jcm15062456

Vancouver

Çiçek G, Açıkgöz SK, Açıkgöz E, Altay S. Pan-Immune-Inflammation Value as a Novel Predictor of Contrast-Associated Acute Kidney Injury in Patients Treated with Primary PCI for STEMI. Journal of Clinical Medicine. 2026;15(6):2456. doi:10.3390/jcm15062456

BibTeX
@article{iek2026,
  author = {Çiçek, Gökhan and Açıkgöz, Sadık Kadri and Açıkgöz, Eser and Altay, Servet},
  title = {Pan-Immune-Inflammation Value as a Novel Predictor of Contrast-Associated Acute Kidney Injury in Patients Treated with Primary PCI for STEMI},
  journal = {Journal of Clinical Medicine},
  year = {2026},
  volume = {15},
  number = {6},
  pages = {2456},
  doi = {10.3390/jcm15062456}
}
Kostenlos starten →